A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

NCT06263959 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: GST-HG131
DRUG: Placebo to match GST-HG131

Sponsor

Fujian Akeylink Biotechnology Co., Ltd.